Loading
Only a handful of insider records exist for LeenLife Pharma International Inc., the last one from 22 December 2016, too few to describe a trend. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
4 of 4 declarations
LeenLife Pharma International Inc. is a company focused on developing innovative pharmaceutical solutions. It is listed on the Toronto Stock Exchange (XTSE).